XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity (Tables)
6 Months Ended
Sep. 30, 2022
Class Of Stock [Line Items]  
Schedule of Stock-based Compensation Expense

Stock-based compensation expense for all stock-based awards consists of the following (in thousands):

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Six Months Ended

 

 

Six Months Ended

 

 

 

September 30, 2022

 

 

September 30, 2021

 

 

September 30, 2022

 

 

September 30, 2021

 

Research and development

 

$

125

 

 

$

80

 

 

$

246

 

 

$

156

 

General and administrative

 

$

548

 

 

$

346

 

 

$

1,087

 

 

$

685

 

Total

 

$

673

 

 

$

426

 

 

$

1,333

 

 

$

841

 

 

Fair Value of Employee Stock Options The fair value of stock options was estimated at the grant date using the following weighted average assumptions:

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Six Months Ended

 

 

Six Months Ended

 

 

 

September 30, 2022

 

 

September 30, 2021

 

 

September 30, 2022

 

 

September 30, 2021

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

95.93

%

 

 

116.83

%

 

 

95.41

%

 

 

116.83

%

Risk-free interest rate

 

 

3.30

%

 

 

0.73

%

 

 

3.18

%

 

 

0.73

%

Expected life of options

 

6.00 years

 

 

6.00 years

 

 

6.00 years

 

 

6.00 years

 

Weighted average grant

   date fair value

 

$

1.85

 

 

$

6.52

 

 

$

1.99

 

 

$

6.52

 

 

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity from March 31, 2022 to September 30, 2022:

 

 

 

Options

Outstanding

 

 

Weighted

Average

Exercise Price

 

 

Aggregate

Intrinsic

Value

 

Outstanding at March 31, 2022

 

 

1,203,671

 

 

$

7.36

 

 

$

71,650

 

Options granted

 

 

199,921

 

 

$

2.56

 

 

$

 

Options cancelled / forfeited

 

 

 

 

$

 

 

$

 

Options exercised

 

 

 

 

$

 

 

$

 

Outstanding at September 30, 2022

 

 

1,403,592

 

 

$

6.68

 

 

$

1,503

 

Vested and Exercisable at September 30, 2022

 

 

339,232

 

 

$

7.57

 

 

$

 

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following at September 30, 2022:

 

Common stock issuable pursuant to options outstanding and reserved under the 2012

   Plan

 

 

1,353,592

 

Common stock reserved under the 2012 Plan

 

 

510,412

 

Common stock reserved under the ESPP

 

 

59,435

 

Common stock reserved under the 2021 Inducement Equity Plan

 

 

700,000

 

Common stock issuable pursuant to restricted stock units outstanding under the 2012 Plan

 

 

12,774

 

Common stock issuable pursuant to options outstanding and reserved under the Inducement Plan

 

 

50,000

 

Total at September 30, 2022

 

 

2,686,213

 

Restricted stock units (RSUs) [Member]  
Class Of Stock [Line Items]  
Summary of Company's RSUs Activity and Performance-Based RSUs Activity

The following table summarizes the Company’s RSUs (not including performance-based RSUs) activity from March 31, 2022 through September 30, 2022:

 

 

Number of

Shares

 

 

Weighted

Average Price

 

Unvested at March 31, 2022

 

 

15,500

 

 

$

10.58

 

Granted

 

 

 

 

$

 

Vested

 

 

(2,726

)

 

$

11.07

 

Cancelled / forfeited

 

 

 

 

$

 

Unvested at September 30, 2022

 

 

12,774

 

 

$

10.47

 

ESPP Shares [Member]  
Class Of Stock [Line Items]  
Fair Value of Employee Stock Options The fair value of ESPP shares was estimated at the purchase period commencement date using the following assumptions:

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Six Months Ended

 

 

Six Months Ended

 

 

 

 

September 30, 2022

 

 

September 30, 2021*

 

 

September 30, 2022

 

 

September 30, 2021*

 

 

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

86.58

%

 

 

0.00

%

 

 

86.58

%

 

 

0.00

%

 

Risk-free interest rate

 

 

3.34

%

 

 

0.00

%

 

 

3.34

%

 

 

0.00

%

 

Expected term

 

6 months

 

 

 

 

 

6 months

 

 

 

 

 

Grant date fair value

 

$

0.82

 

 

$

 

 

$

0.82

 

 

$

 

 

*There were no participants in the ESPP for the purchase periods beginning March 1, 2021 or September 1, 2021.